The United States limits the provision of Eli Lilly’s COVID-19 antibody therapy to three states
(Reuters) – The U.S. Department of Health and Human Services said it would limit the distribution of Eli Lilly and Co’s COVID-19 antibody therapy to three states due to concerns about t…
